Asia Pacific Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country and Geography

TIPRE00015127 | Pages: 174 | Pharmaceuticals | Oct 2020 | Type: Regional | Status: Published

Market Introduction

This research report provides insights into the global Cancer Vaccines market. The cancer vaccine is a vaccine which either treats existing cancer or prevents cancer from developing. Established cancer treatment vaccines are known as therapeutic cancer vaccines. Some / many of the vaccines are "autologous," are made from patient samples, and are unique to that patient. Additionally the cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. For instance, Cervarix, Gardasil, Gardasil-9 and Hepatitis B (HBV) vaccine (HEPLISAV-B) are Preventive Cancer Vaccines. Whereas, Bacillus Calmette-Guérin (BCG), Sipuleucel-T (Provenge) are Therapeutic Cancer Vaccines

Market Overview and Dynamics

The Asia Pacific cancer vaccines market was valued at US$ 861.55 million in 2019 and is projected to reach US$ 3,131.09 million by 2027; it is expected to grow at a CAGR of 17.9% during the forecast period. Factors driving the market growth include large cancer patient population, increasing number of research studies, growing government support, and increasing number of startups and biotech companies in this region. However, the challenges in cancer vaccines industry like higher cost of cancer vaccines restrains the growth of the market.

Key Market Segments

In terms of technology, the recombinant cancer vaccines segment held the largest share of the market in 2019; and also is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the preventive cancer vaccine segment held a larger share of the market in 2019 and also is estimated to register a higher market share in the market during the forecast period. Likewise, in terms of end user, the pediatrics segment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period.

Major Sources and Companies Listed

The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Canadian MedTech Manufacturers’ Alliance are some of the major primary and secondary sources for the Asia Pacific cancer vaccines market included in the report.

Reasons to buy the report

  • To understand the Asia Pacific cancer vaccines market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacific cancer vaccines market
  • Efficiently plan M&A and partnership deals in the Asia Pacific cancer vaccines market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the Asia Pacific cancer vaccines market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region

Asia Pacific Cancer vaccines Market Segmentation

By Technology

  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector Cancer Vaccines

Asia Pacific Cancer Vaccines Market – By Type

  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccine

Asia Pacific Cancer Vaccines Market – By Indication

  • Cervical Cancer
  • Prostate Cancer
  • Other Indications

Asia Pacific Cancer Vaccines Market– By End Use

  • Pediatrics
  • Adults

Company Profiles

  • AstraZeneca
  • GlaxoSmithKline plc.
  • Aduro Biotech Inc
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb
  • Moderna, Inc.
  • OncBioMune Pharmaceuticals Inc.
  • MaxiVAX
  • Nouscom

 

1.            Introduction. 17

1.1         Scope of the Study. 17

1.2         The Insight Partners Research Report Guidance. 17

1.3         Market Segmentation. 19

1.3.1        Asia Pacific Cancer Vaccines Market – By Technology. 21

1.3.2        Asia Pacific Cancer Vaccines Market – By Type. 21

1.3.3        Asia Pacific Cancer Vaccines Market – By Indication. 21

1.3.4        Asia Pacific Cancer Vaccines Market– By End Use. 21

1.3.5        Asia Pacific Cancer Vaccines Market– By Region. 22

2.            Cancer Vaccines Market – Key Takeaways. 23

3.            Research Methodology. 27

3.1         Coverage. 29

3.2         Secondary Research. 29

3.3         Primary Research. 30

4.            Cancer Vaccines – Market Landscape. 31

4.1         Overview.. 31

4.2         PEST Analysis. 31

4.3         Expert Opinion. 32

5.            Asia Pacific Cancer Vaccines Market – Industry Dynamics. 33

5.1         Key Drivers. 33

5.1.1        Increase in Prevalence of Cancer Worldwide. 33

5.1.2        Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines. 34

5.2         Key Market Restraints. 35

5.2.1        Less Number of Commercially Available Vaccines for Treatment of Cancer 35

5.2.2        Higher Cost of Cancer Vaccines. 35

5.3         Key Market Opportunities. 36

5.3.1        Emerging Markets in Developing Countries. 36

5.4         Future Trends. 36

5.4.1        Growing Research and Development Activities. 36

5.5         Impact analysis. 38

6.            Cancer Vaccines Market – Regional Analysis. 39

6.1         Asia Pacific Cancer Vaccines Market Revenue Forecast And Analysis. 39

7.            Asia Pacific Cancer Vaccines Market Analysis – By Technology. 40

7.1         Overview.. 40

7.2         Cancer Vaccines Market Share, by Technology, 2019 and 2027 (%) 40

7.3         Dendritic Cells Cancer Vaccine. 42

7.3.1        Overview.. 42

7.3.2        Dendritic Cells Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 43

7.5         Recombinant Cancer Vaccines. 44

7.5.1        Overview.. 44

7.5.2        Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 45

7.6         Antigen Cancer Vaccines. 46

7.6.1        Overview.. 46

7.6.2        Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 47

7.7         Whole Cell Cancer Vaccines. 48

7.7.1        Overview.. 48

7.7.2        Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 49

7.8         Viral Vector Cancer Vaccines. 50

7.8.1        Overview.. 50

7.8.2        Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 51

8.            Cancer Vaccines Market Analysis – By Type. 52

8.1         Overview.. 52

8.2         Cancer Vaccines Market Revenue Share, by Type (2019 and 2027) 52

8.3         Preventive Cancer Vaccines. 54

8.3.1        Overview.. 54

8.3.2        Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 55

8.4         Therapeutic Cancer Vaccines. 56

8.4.1        Overview.. 56

8.4.2        Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 57

9.            Cancer Vaccines Market Analysis – By Indication. 58

9.1         Overview.. 58

9.2         Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027) 58

9.3         Cervical Cancer 60

9.3.1        Overview.. 60

9.3.2        Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 61

9.4         Prostate Cancer 62

9.4.1        Overview.. 62

9.4.2        Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 63

9.5         Other Indications. 64

9.5.1        Overview.. 64

9.5.2        Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 65

10.         Cancer Vaccines Market Analysis – By End Use. 66

10.1      Overview.. 66

10.2      Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027) 66

10.3      Pediatrics. 67

10.3.1     Overview.. 67

10.3.2     Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 68

10.4      Adults. 69

10.4.1     Overview.. 69

10.4.2     Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 70

11.         Cancer Vaccines Market – Geographic Analysis. 71

11.1      Asia Pacific: Cancer Vaccines Market 71

11.1.1     Overview.. 71

11.1.2     Asia Pacific: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million) 72

11.1.3     Asia Pacific: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 73

11.1.4     Asia Pacific: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 74

11.1.5     Asia Pacific: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 74

11.1.6     Asia Pacific: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 75

11.1.7     Asia Pacific: Cancer Vaccines Market, by Country, 2019 & 2027 (%) 75

11.1.8     China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 76

11.1.8.1       China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 77

11.1.8.2       China: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 78

11.1.8.3       China: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 78

11.1.8.4       China: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 79

11.1.8.5       China: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 80

11.1.9     Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 81

11.1.9.1       Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 82

11.1.9.2       Japan: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 83

11.1.9.3       Japan: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 83

11.1.9.4       Japan: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 84

11.1.9.5       Japan: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 85

11.1.10  India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 86

11.1.10.1    India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 87

11.1.10.2    India: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 88

11.1.10.3    India: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 89

11.1.10.4    India: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 89

11.1.10.5    India: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 91

11.1.11  South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 92

11.1.11.1    South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 93

11.1.11.2    South Korea: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 94

11.1.11.3    South Korea: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 94

11.1.11.4    South Korea: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 95

11.1.11.5    South Korea: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 96

11.1.12  Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 97

11.1.12.1    Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 98

11.1.12.2    Australia: Cancer Vaccines Market, by Type, 2018–2027 (USD Million) 99

11.1.12.3    Australia: Cancer Vaccines Market, by Indication 2018–2027 (USD Million) 99

11.1.12.4    Australia: Cancer Vaccines Market, by Technology 2018–2027 (USD Million) 100

11.1.12.5    Australia: Cancer Vaccines Market, by End User, 2018–2027 (USD Million) 101

12.         Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market 102

12.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic. 102

13.         Cancer Vaccines Market – Industry Landscape. 104

13.1      Overview.. 104

13.2      Growth Strategies Done by the Companies in the Market, (%) 105

13.3      Organic Developments. 106

13.3.1     Overview.. 106

13.4      Inorganic Developments. 107

13.4.1     Overview.. 107

14.         Company Profiles. 109

14.1      CSL Limited. 109

14.1.1     Key Facts. 109

14.1.2     Business Description. 109

14.1.3       Products and Services. 110

14.1.4     Financial Overview.. 111

14.1.5     SWOT Analysis. 113

14.1.6       Key Developments. 114

14.2      ADURO BIOTECH INC. 115

14.2.1     Key Facts. 115

14.2.2     Business Description. 115

14.2.3       Products and Services. 116

14.2.4     Financial Overview.. 117

14.2.5     SWOT Analysis. 118

14.2.6     Key Developments. 119

14.3      Astellas Pharma Inc. 120

14.3.1     Key Facts. 120

14.3.2     Business Description. 120

14.3.3     Products and Services. 121

14.3.4     Financial Overview.. 122

14.3.5     SWOT Analysis. 124

14.3.6     Key Developments. 125

14.4      Bristol-Myers Squibb Company. 126

14.4.1     Key Facts. 126

14.4.2     Business Description. 126

14.4.3     Products and Services. 127

14.4.4     Financial Overview.. 128

14.4.5     SWOT Analysis. 131

14.4.6     Key Developments. 132

14.5      GlaxoSmithKline plc. 133

14.5.1     Key Facts. 133

14.5.2     Business Description. 133

14.5.3     Products and Services. 134

14.5.4     Financial Overview.. 135

14.5.5     SWOT Analysis. 139

14.5.6     Key Developments. 140

14.6      Dendreon. 141

14.6.1     Key Facts. 141

14.6.2     Business Description. 141

14.6.3     Products and Services. 141

14.6.4     Financial Overview.. 141

14.6.5     SWOT Analysis. 142

14.6.6     Key Developments. 143

14.7      AstraZeneca. 144

14.7.1     Key Facts. 144

14.7.2     Business Description. 144

14.7.3     Products and Services. 145

14.7.4     Financial Overview.. 146

14.7.5     SWOT Analysis. 148

14.7.6     Key Developments. 149

14.8      Merck & Co., Inc. 150

14.8.1     Key Facts. 150

14.8.2     Business Description. 150

14.8.3     Products and Services. 151

14.8.4     Financial Overview.. 152

14.8.5     SWOT Analysis. 156

14.8.6     Key Developments. 156

14.9      Sanofi (Sanofi Pasteur) 158

14.9.1     Key Facts. 158

14.9.2     Business Description. 158

14.9.3     Products and Services. 159

14.9.4     Financial Overview.. 160

14.9.5     SWOT Analysis. 164

14.9.6     Key Developments. 164

14.10   OSE Immunotherapeutics. 166

14.10.1  Key Facts. 166

14.10.2  Business Description. 166

14.10.3  Products and Services. 167

14.10.4  Financial Overview.. 168

14.10.5  SWOT Analysis. 170

14.10.6  Key Developments. 170

15.         Appendix. 172

15.1      Glossary of Terms

. 172

LIST OF TABLES

Table 1.             Asia Pacific Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million) 73

Table 2.             Asia Pacific Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 74

Table 3.             Asia Pacific Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 74

Table 4.             Asia Pacific Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 75

Table 5.             China Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 78

Table 6.             China Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 78

Table 7.             China Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 79

Table 8.             China Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 80

Table 9.             Japan Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 83

Table 10.          Japan Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 83

Table 11.          Japan Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 84

Table 12.          Japan Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 85

Table 13.          India Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 88

Table 14.          India Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 89

Table 15.          India Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 89

Table 16.          India Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 91

Table 17.          South Korea Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 94

Table 18.          South Korea Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 94

Table 19.          South Korea Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 95

Table 20.          South Korea Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 96

Table 21.          Incidence, Mortality and Prevalence by cancer site, Australia, 2018. 97

Table 22.          Australia Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 99

Table 23.          Australia Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 99

Table 24.          Australia Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million) 100

Table 25.          Australia Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 101

Table 26.          Organic Developments Done By Companies. 106

Table 27.          Inorganic Developments Done By Companies. 107

Table 28.          Glossary of Terms, Cancer Vaccines Market

172

LIST OF FIGURES

Figure 1.           Cancer Vaccines Market Segmentation. 19

Figure 2.           Cancer Vaccines Segmentation – By Region. 20

Figure 3.           Asia Pacific Cancer Vaccines Market Overview.. 23

Figure 4.           In Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market in 2019. 24

Figure 5.           Cancer Vaccines Market in Japan to Show Remarkable Growth During Forecast Period. 25

Figure 7.           Asia Pacific PEST Analysis. 31

Figure 8.           Cancer Statistics, 2020. 33

Figure 9.           Cancer Vaccines Market Impact Analysis of Driver and Restraints. 38

Figure 10.        Asia Pacific Cancer Vaccines Market – Revenue Forecast And Analysis – 2019- 2027. 39

Figure 11.        Cancer Vaccines market Share, by Technology, 2019 and 2027 (%) 40

Figure 12.        Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 43

Figure 13.        Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 45

Figure 14.        Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 47

Figure 15.        Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 49

Figure 16.        Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 51

Figure 17.        Cancer Vaccines Market Revenue Share, by Type (2019 and 2027) 52

Figure 18.        Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 55

Figure 19.        Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 57

Figure 20.        Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027) 58

Figure 21.        Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 61

Figure 22.        Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 63

Figure 23.        Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 65

Figure 24.        Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027) 66

Figure 25.        Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 68

Figure 26.        Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 70

Figure 27.        Asia Pacific: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million) 71

Figure 28.        Asia Pacific Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million) 72

Figure 29.        China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 77

Figure 30.        Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 82

Figure 31.        India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 87

Figure 32.        South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 93

Figure 33.        Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 98

Figure 34.        Impact of COVID-19 Pandemic in Asia-Pacific Country Markets. 103

Figure 35.        Growth Strategies Done by the Companies in the Market, (%) 105

 

The List of Companies - Asia Pacific Cancer Vaccines Market

  1. AstraZeneca
  2. GlaxoSmithKline plc.
  3. Aduro Biotech Inc
  4. Pfizer Inc.
  5. Sanofi
  6. Bristol-Myers Squibb
  7. Moderna, Inc.
  8. OncBioMune Pharmaceuticals Inc.
  9. MaxiVAX
  10. Nouscom
  • It provides understanding of the Asia Pacific Cancer Vaccines market landscape and identifies Cancer Vaccines market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive market landscape.
  • It helps efficiently plan merger and acquisition, and partnership deals in the Cancer Vaccines market in Asia Pacific by identifying market segments with the most promising probable sales.
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of the market performance of various segments.
  • It provides revenue forecast of the market based on various segments for the period from 2019 to 2027.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000